Last reviewed · How we verify
NCT04783480: Birthly
Can Birthly, an Online Childbirth Education Platform, Reduce Pregnancy-related Anxiety Compared to Usual Care
NA trial testing Birthly in Pregnancy, High Risk in 90 participants. Completed in 1 June 2022.
1 June 2022
Quick facts
| Lead sponsor | University of Pennsylvania |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 90 |
| Start date | 12 April 2021 |
| Primary completion | 1 June 2022 |
| Estimated completion | 1 June 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Birthly
- Standard of care
Conditions studied
- Pregnancy, High Risk — all drugs for Pregnancy, High Risk →
Sponsor
University of Pennsylvania
Who can join
18 and older, female only, with Pregnancy, High Risk. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A pilot randomized, controlled trial comparing Birthly, (an online platform for live group prenatal classes taught by childbirth educators, nurses, and lactation consultants) plus standard prenatal care versus standard prenatal care alone among women with high risk pregnancies.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
An interactive childbirth education platform to improve pregnancy-related anxiety: a randomized trial.
Zafman KB, Riegel ML, Levine LD, Hamm RF. · · 2023 · cited 8× · PMID 37054807 · DOI 10.1016/j.ajog.2023.04.007
Verify or expand the search:
- PubMed search for NCT04783480
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pregnancy, High Risk
Currently open trials in the same condition.
- NCT05388643 — Early Detection of Gestational Diabetes Mellitus in Pregnancy · NA · recruiting
- NCT06654713 — Commercial or Open Source Closed Loop Impact on Pregnancy Study · recruiting
- NCT05317585 — Continuous Glucose Monitor Use in Pregnancy · NA · recruiting
- NCT05790252 — Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE) · Phase 3 · recruiting
- NCT05909046 — A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE · NA · recruiting
Other University of Pennsylvania trials
Trials by the same sponsor.
- NCT06081153 — Mechanistic Clinical Trial of PCSK9 Inhibition for AAA · EARLY_PHASE1 · not yet recruiting
- NCT07415772 — Effect of cTBS on Startle and TMS-evoked BOLD · NA · not yet recruiting
- NCT07489430 — DaxibotulinumtoxinA for Blepharospasm · Phase 2 · not yet recruiting
- NCT07463131 — Negative Income Tax Trial · NA · not yet recruiting
- NCT06645769 — Na-Phenylbutyrate VAscular Trial · EARLY_PHASE1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04783480 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Pennsylvania
- Last refreshed: 18 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04783480.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing